EnteroMedics (ETRM) Stock: Gaining On New Patent

EnteroMedics Inc (NASDAQ: ETRM) is having an incredibly strong time in the market at the moment, and for good reason. The company has received a new patent. This led to investor excitement and ultimately gains in the value of the stock, prompting our partners at Trade Ideas to alert us to the movement. At the moment (10:34), ETRM is trading at $6.13 per share after a gain of $0.36 per share (6.24%) thus far today.

ETRM Is Awarded A New Patent

As mentioned above, EnteroMedics is having a strong day in the market at the moment after it was awarded a new patent. The patent is for “Systems for regulation of blood pressure and heart rate.” The abstract of the patent is as follows:

A method and apparatus for treating a condition associated with the impaired blood pressure and/or heart rate in a subject comprising applying an electrical treatment signal, wherein the electrical treatment signal is selected to at least partially block nerve impulses, or in some embodiments to augment nerve impulses.”

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on ETRM. In particular, we’re interested in this patent and the use of the patent to protect revenue-generating products in the future. We’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required

[Image Courtesy of Wikimedia]

Leave a Comment